Literature DB >> 26153467

Prospective assessment of white matter integrity in adult stem cell transplant recipients.

D D Correa1, Y Wang2,3, J D West2, K K Peck4, J C Root5, R E Baser6, H T Thaler6, T B Shore7, A Jakubowski8, A J Saykin2, N Relkin9.   

Abstract

Hematopoietic stem cell transplantation (HSCT) is often used in the treatment of hematologic disorders. Although it can be curative, the pre-transplant conditioning regimen can be associated with neurotoxicity. In this prospective study, we examined white matter (WM) integrity with diffusion tensor imaging (DTI) and neuropsychological functioning before and one year after HSCT in twenty-two patients with hematologic disorders and ten healthy controls evaluated at similar intervals. Eighteen patients received conditioning treatment with high-dose (HD) chemotherapy, and four had full dose total body irradiation (fTBI) and HD chemotherapy prior to undergoing an allogeneic or autologous HSCT. The results showed a significant decrease in mean diffusivity (MD) and axial diffusivity (AD) in diffuse WM regions one year after HSCT (p-corrected <0.05) in the patient group compared to healthy controls. At baseline, patients treated with allogeneic HSCT had higher MD and AD in the left hemisphere WM than autologous HSCT patients (p-corrected <0.05). One year post-transplant, patients treated with allogeneic HSCT had lower fractional anisotropy (FA) and higher radial diffusivity (RD) in the right hemisphere and left frontal WM compared to patients treated with autologous HSCT (p-corrected <0.05).There were modest but significant correlations between MD values and cognitive test scores, and these were greatest for timed tests and in projection tracts. Patients showed a trend toward a decline in working memory, and had lower cognitive test scores than healthy controls at the one-year assessment. The findings suggest a relatively diffuse pattern of alterations in WM integrity in adult survivors of HSCT.

Entities:  

Keywords:  Cognitive; Diffusion tensor imaging; Hematopoietic stem cell transplantation; Magnetic resonance imaging

Mesh:

Year:  2016        PMID: 26153467      PMCID: PMC4706509          DOI: 10.1007/s11682-015-9423-3

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  54 in total

1.  Diffusion tensor MR imaging of the human brain.

Authors:  C Pierpaoli; P Jezzard; P J Basser; A Barnett; G Di Chiro
Journal:  Radiology       Date:  1996-12       Impact factor: 11.105

2.  Neurocognitive functions and quality of life in haematological patients receiving haematopoietic stem cell grafts: a one-year follow-up pilot study.

Authors:  Helena Harder; Hugo J Duivenvoorden; Arthur R van Gool; Jan J Cornelissen; Martin J van den Bent
Journal:  J Clin Exp Neuropsychol       Date:  2006-04       Impact factor: 2.475

3.  Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

Authors:  Stephen M Smith; Thomas E Nichols
Journal:  Neuroimage       Date:  2008-04-11       Impact factor: 6.556

4.  Higher busulfan dose intensity does not improve outcomes of patients undergoing allogeneic haematopoietic cell transplantation following fludarabine, busulfan-based reduced toxicity conditioning.

Authors:  Mehdi Hamadani; Michael Craig; Gary S Phillips; Jame Abraham; William Tse; Aaron Cumpston; Laura Gibson; Scot C Remick; Pamela Bunner; Sonia Leadmon; Patrick Elder; Craig Hofmeister; Sam Penza; Yvonne Efebera; Leslie Andritsos; Ramiro Garzon; Don M Benson; William Blum; Steven M Devine
Journal:  Hematol Oncol       Date:  2011-02-28       Impact factor: 5.271

5.  Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.

Authors:  P Sostak; C S Padovan; T A Yousry; G Ledderose; H-J Kolb; A Straube
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

Review 6.  Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis.

Authors:  Michelle Monje; Jörg Dietrich
Journal:  Behav Brain Res       Date:  2011-05-23       Impact factor: 3.332

7.  Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors.

Authors:  M Peper; S Steinvorth; P Schraube; S Fruehauf; R Haas; B N Kimmig; F Lohr; F Wenz; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

Review 8.  The double-edged sword: Neurotoxicity of chemotherapy.

Authors:  Rajiv S Magge; Lisa M DeAngelis
Journal:  Blood Rev       Date:  2014-09-28       Impact factor: 8.250

9.  T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin.

Authors:  Ann A Jakubowski; Trudy N Small; James W Young; Nancy A Kernan; Hugo Castro-Malaspina; Katherine C Hsu; Miguel-Angel Perales; Nancy Collins; Christine Cisek; Michelle Chiu; Marcel R M van den Brink; Richard J O'Reilly; Esperanza B Papadopoulos
Journal:  Blood       Date:  2007-08-23       Impact factor: 22.113

10.  Anticancer agents are potent neurotoxins in vitro and in vivo.

Authors:  Wojciech Rzeski; Susanne Pruskil; Alexander Macke; Ursula Felderhoff-Mueser; Anne Katrin Reiher; Friederike Hoerster; Corina Jansma; Bozena Jarosz; Vanya Stefovska; Petra Bittigau; Chrysanthy Ikonomidou
Journal:  Ann Neurol       Date:  2004-09       Impact factor: 10.422

View more
  9 in total

1.  Structural brain alterations following adult non-CNS cancers: a systematic review of the neuroimaging literature.

Authors:  Ali Amidi; Lisa M Wu
Journal:  Acta Oncol       Date:  2019-02-07       Impact factor: 4.089

2.  Pretransplantation Cognitive Dysfunction in Advanced-Age Hematologic Cancers: Predictors and Associated Outcomes.

Authors:  James C Root; Claudine Campbell; Xiomara Rocha-Cadman; Nicole Kasven-Gonzalez; Molly Maloy; Jessica Flynn; Sean M Devlin; Ann A Jakubowski
Journal:  Biol Blood Marrow Transplant       Date:  2020-05-21       Impact factor: 5.742

3.  Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT.

Authors:  Martin Schmidt-Hieber; Dan Engelhard; Andrew Ullmann; Per Ljungman; Johan Maertens; Rodrigo Martino; Montserrat Rovira; Peter J Shaw; Christine Robin; Maura Faraci; Jenny Byrne; Kerstin Schäfer-Eckart; Hermann Einsele; Edgar Faber; Luigi Rigacci; Riccardo Saccardi; Aitana Balaguer-Rosello; Cecilia Isaksson; Maximilian Christopeit; Gloria Tridello; Junfeng Wang; Nina Knelange; Malgorzata Mikulska; Simone Cesaro; Jan Styczynski
Journal:  J Neurol       Date:  2019-10-29       Impact factor: 4.849

4.  International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients.

Authors:  Sabine Deprez; Shelli R Kesler; Andrew J Saykin; Daniel H S Silverman; Michiel B de Ruiter; Brenna C McDonald
Journal:  J Natl Cancer Inst       Date:  2018-03-01       Impact factor: 13.506

5.  Measuring decline in white matter integrity after systemic treatment for breast cancer: omitting skeletonization enhances sensitivity.

Authors:  Yasmin Mzayek; Michiel B de Ruiter; Hester S A Oldenburg; Liesbeth Reneman; Sanne B Schagen
Journal:  Brain Imaging Behav       Date:  2021-06       Impact factor: 3.978

6.  Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT.

Authors:  Mussie Msghina; Katarina Le Blanc; Erik Boberg; Ellen Iacobaeus; Myrto Sklivanioti Greenfield; Yanlu Wang
Journal:  Bone Marrow Transplant       Date:  2021-12-04       Impact factor: 5.174

7.  Cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma undergoing standard chemotherapy: a longitudinal feasibility study.

Authors:  Haryana M Dhillon; Karla Gough; Priscilla Gates; Meinir Krishnasamy; Carlene Wilson; Eliza A Hawkes; Vincent Doré; Yuliya Perchyonok; Christopher C Rowe; Adam K Walker; Janette L Vardy; Michiel B de Ruiter; Tania Cushion
Journal:  Support Care Cancer       Date:  2022-06-14       Impact factor: 3.359

Review 8.  Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.

Authors:  Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler
Journal:  Oncologist       Date:  2021-07-12

Review 9.  Cognitive Effects of Cancer and Cancer Treatments.

Authors:  Tim A Ahles; James C Root
Journal:  Annu Rev Clin Psychol       Date:  2018-01-18       Impact factor: 22.098

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.